MARKET

MSCLF

MSCLF

Satellos Bioscience Inc
OTCMQB
0.648
+0.008
+1.25%
Closed 14:11 01/16 EST
OPEN
0.650
PREV CLOSE
0.640
HIGH
0.650
LOW
0.640
VOLUME
25.00K
TURNOVER
16.21K
52 WEEK HIGH
0.686
52 WEEK LOW
0.390
MARKET CAP
120.21M
P/E (TTM)
-4.6121
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MSCLF last week (0112-0116)?
Weekly Report · 13h ago
Weekly Report: what happened at MSCLF last week (0105-0109)?
Weekly Report · 01/12 09:16
Weekly Report: what happened at MSCLF last week (1229-0102)?
Weekly Report · 01/05 09:14
Weekly Report: what happened at MSCLF last week (1222-1226)?
Weekly Report · 12/29/2025 09:14
Weekly Report: what happened at MSCLF last week (1215-1219)?
Weekly Report · 12/22/2025 09:14
Weekly Report: what happened at MSCLF last week (1208-1212)?
Weekly Report · 12/15/2025 09:16
Satellos Bioscience Wins FDA and Global Clearance for Phase 2 Duchenne Study
Reuters · 12/09/2025 12:01
SATELLOS RECEIVES CLEARANCE BY U.S. FDA AND GLOBAL REGULATORS TO INITIATE PEDIATRIC PHASE 2 STUDY OF SAT-3247 FOR DUCHENNE MUSCULAR DYSTROPHY
Reuters · 12/09/2025 12:00
More
About MSCLF
Satellos Bioscience Inc. is a Canada-based clinical-stage drug development company. The Company is focused on restoring natural muscle repair and regeneration in degenerative muscle diseases. Through its research, the Company has developed SAT-3247, a first-of-its-kind, orally administered small molecule drug designed to address deficits in muscle repair and regeneration. SAT-3247 targets AAK1, a key protein that has identified as capable of replacing the signal normally provided by dystrophin in muscle stem cells to effect repair and regeneration. It is also leveraging its proprietary discovery platform MyoReGenX to identify additional muscle diseases or injury conditions where restoring muscle repair and regeneration may have therapeutic benefit and represent future clinical development opportunities. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process.

Webull offers Satellos Bioscience Inc stock information, including OTCMQB: MSCLF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MSCLF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MSCLF stock methods without spending real money on the virtual paper trading platform.